Who are Cannabidiol (CBD) Extract's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): MediCabilis CBD Oil, Placebo Matched to Low-Dose Cannabidiol, Cannabidiol (CBD) Oil Capsules, Moderate-Dose Cannabidiol, MPL-001 (CBD: THC 25:1), Cannabis Extract Oil SR Capsule.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cannabidiol-cbd-extract.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cannabidiol (CBD) Extract — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cannabidiol (CBD) Extract (Cannabidiol (CBD) Extract) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cannabinoid receptor modulator. Area: Neurology, Psychiatry, Immunology.

phase 3 Cannabinoid receptor modulator CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor Neurology, Psychiatry, Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Cannabidiol (CBD) Extract (Cannabidiol (CBD) Extract) — Milton S. Hershey Medical Center. Cannabidiol modulates endocannabinoid signaling and multiple receptor pathways to reduce inflammation, anxiety, and seizure activity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Cannabidiol (CBD) Extract TARGET	Cannabidiol (CBD) Extract	Milton S. Hershey Medical Center	phase 3	Cannabinoid receptor modulator	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor
MediCabilis CBD Oil	MediCabilis CBD Oil	Gold Coast Hospital and Health Service	marketed	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor (multiple targets)
Placebo Matched to Low-Dose Cannabidiol	Placebo Matched to Low-Dose Cannabidiol	Wayne State University	phase 3	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor
Cannabidiol (CBD) Oil Capsules	Cannabidiol (CBD) Oil Capsules	McMaster University	phase 3	Phytocannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor (multi-target)
Moderate-Dose Cannabidiol	Moderate-Dose Cannabidiol	Wayne State University	phase 3	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor
MPL-001 (CBD: THC 25:1)	MPL-001 (CBD: THC 25:1)	McMaster University	phase 3	Cannabinoid combination	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor
Cannabis Extract Oil SR Capsule	Cannabis Extract Oil SR Capsule	University of Sao Paulo General Hospital	marketed	Cannabinoid receptor modulator	CB1 receptor, CB2 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cannabinoid receptor modulator class)

Milton S. Hershey Medical Center · 1 drug in this class
University of Sao Paulo General Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cannabidiol (CBD) Extract — Competitive Intelligence Brief. https://druglandscape.com/ci/cannabidiol-cbd-extract. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing